Jiaying Zhong

1.1k total citations
32 papers, 689 citations indexed

About

Jiaying Zhong is a scholar working on Infectious Diseases, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Jiaying Zhong has authored 32 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Jiaying Zhong's work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Jiaying Zhong is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Jiaying Zhong collaborates with scholars based in China, United States and Australia. Jiaying Zhong's co-authors include Shicheng Yan, Zhigang Zou, Yuandong Yan, William C. Groutas, Ruyi Wang, Yunzhi Ling, Zhongfang Wang, Weichang Hao, Qian Zheng and Jianlin Shi and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jiaying Zhong

29 papers receiving 682 citations

Peers

Jiaying Zhong

RESE

Beatriz Salinas Spain

Bapurao Surnar United States

Xiaoyi Jiang China

Liting Ren China

Shumin Zhang China

Jiayi Liang China

Sanjay Kulkarni India

Pengfei Cai China

Yi Luan United States

Lingjie He China

Beatriz Salinas Spain

Jiaying Zhong

205 ×1.1

25 ×0.1

RESE

42 ×0.3

318 ×2.8

112 ×1.1

Citations per year, relative to Jiaying Zhong Jiaying Zhong (= 1×) peers Beatriz Salinas

Countries citing papers authored by Jiaying Zhong

Since Specialization

Citations

This map shows the geographic impact of Jiaying Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaying Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaying Zhong more than expected).

Fields of papers citing papers by Jiaying Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaying Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaying Zhong. The network helps show where Jiaying Zhong may publish in the future.

Co-authorship network of co-authors of Jiaying Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaying Zhong. A scholar is included among the top collaborators of Jiaying Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaying Zhong. Jiaying Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, H., Guichang Li, Kaiwen Zhou, et al.. (2025). Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods. Vaccines. 13(3). 304–304. 2 indexed citations

Yang, Xiaoyun, Guichang Li, Tingting Cui, et al.. (2025). Immune imprinting toward SARS-CoV-2 XBB: implications for vaccine strategy and variant risk assessment. Signal Transduction and Targeted Therapy. 10(1). 372–372.

Huang, Mingzhu, Tingting Cui, Siyi Liu, et al.. (2024). Blended BA.5 infection within 8 days after a boosted bivalent mRNA vaccination strengthens and lengthens the host immunity. Journal of Medical Virology. 96(3). e29544–e29544.

Yan, Yuandong, Ruyi Wang, Qian Zheng, et al.. (2023). Nonredox trivalent nickel catalyzing nucleophilic electrooxidation of organics. Nature Communications. 14(1). 7987–7987. 89 indexed citations

Wang, Zhongfang, Xiaoyun Yang, Yumin Zhou, et al.. (2022). SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies. Signal Transduction and Targeted Therapy. 7(1). 132–132. 19 indexed citations

He, Lei, Jiaying Zhong, Guichang Li, et al.. (2022). Development of SARS‐CoV‐2 animal vaccines using a stable and efficient NDV expression system. Journal of Medical Virology. 95(1). e28237–e28237. 4 indexed citations

Zhong, Jiaying, Shuo Liu, Tingting Cui, et al.. (2022). Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants. Emerging Microbes & Infections. 11(1). 2689–2697. 20 indexed citations

Wang, Zhongfang, Xiaoyun Yang, Jiaying Zhong, et al.. (2021). Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection. Nature Communications. 12(1). 1724–1724. 75 indexed citations

Zhong, Jiaying, Haijun Zhao, Zhijuan Lin, et al.. (2021). SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia. Scientific Reports. 11(1). 17012–17012. 6 indexed citations

10.

Ma, Yunhan, Yingyu Chen, Mengya Zhong, et al.. (2021). Leflunomide Inhibits rat-to-Mouse Cardiac Xenograft Rejection by Suppressing Adaptive Immune Cell Response and NF-κB Signaling Activation. Cell Transplantation. 30. 4211112359–4211112359. 3 indexed citations

11.

Wang, Zhongfang, Xiaoyun Yang, Yumin Zhou, et al.. (2020). COVID-19 Severity Correlates with Weaker T-Cell Immunity, Hypercytokinemia, and Lung Epithelium Injury. American Journal of Respiratory and Critical Care Medicine. 202(4). 606–610. 31 indexed citations

12.

Wang, Jinling, Daowei Yang, Junsheng Wang, et al.. (2020). BPTES inhibits anthrax lethal toxin-induced inflammatory response. International Immunopharmacology. 85. 106664–106664. 8 indexed citations

13.

McAlpine, Indrawan, Michelle Tran‐Dubé, Fen Wang, et al.. (2015). Synthesis of Small 3-Fluoro- and 3,3-Difluoropyrrolidines Using Azomethine Ylide Chemistry. The Journal of Organic Chemistry. 80(14). 7266–7274. 50 indexed citations

14.

Yang, Qingliang, Yi Li, Dengfeng Dou, et al.. (2008). Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents. Archives of Biochemistry and Biophysics. 475(2). 115–120. 14 indexed citations

15.

Wei, Liuqing, Zhong Lai, Kevin R. Alliston, et al.. (2004). Mechanism-based inactivation of human leukocyte elastase via an enzyme-induced sulfonamide fragmentation process. Archives of Biochemistry and Biophysics. 429(1). 60–70. 5 indexed citations

16.

Zhong, Jiaying & William C. Groutas. (2004). Recent Developments in the Design of Mechanism-based and Alternate Substrate Inhibitors of Serine Proteases. Current Topics in Medicinal Chemistry. 4(12). 1203–1216. 34 indexed citations

17.

Zhong, Jiaying, Zhong Lai, Kevin R. Alliston, et al.. (2004). Serendipitous discovery of an unexpected rearrangement leads to two new classes of potential protease inhibitors. Bioorganic & Medicinal Chemistry. 12(23). 6249–6254. 1 indexed citations

18.

Zhong, Jiaying, et al.. (2004). Potential Protease Inhibitors Based on a Functional Cyclic Sulfamide Scaffold.. ChemInform. 35(44). 1 indexed citations

19.

Zhong, Jiaying, et al.. (2003). Design, synthesis, and in vitro evaluation of inhibitors of human leukocyte elastase based on a functionalized cyclic sulfamide scaffold. Bioorganic & Medicinal Chemistry. 12(3). 589–593. 23 indexed citations

20.

Wei, Liuqing, et al.. (2003). Noncovalent inhibitors of human leukocyte elastase based on the 4-imidazolidinone scaffold. Bioorganic & Medicinal Chemistry. 11(23). 5149–5153. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact